Today: 7 February 2026
Subscribe
Browse Category

NYSE:MDT News 21 August 2025 - 30 January 2026

Boston Scientific stock snaps a 4-day run — what to watch before Feb. 4 earnings

Boston Scientific stock snaps a 4-day run — what to watch before Feb. 4 earnings

Boston Scientific shares fell 1.6% to $92.33 Thursday, ending a four-day rally on heavy volume after the company completed its acquisition of Nalu Medical. The stock underperformed sector peers as investors awaited fourth-quarter results due Feb. 4 and looked for updates on recent deal activity, including the $14.5 billion Penumbra purchase.
30 January 2026
······
Medtronic stock slips as year-end trading thins and Fed minutes loom

Medtronic stock slips as year-end trading thins and Fed minutes loom

NEW YORK, December 29, 2025, 23:17 ET — Market closed Medtronic plc shares edged lower on Monday, closing down about 0.4% at $96.15, in a quiet start to the market’s final three sessions of the year. Yahoo Finance The move mattered less for the size of the drop than for what it signaled: investors are de-risking into year-end while waiting for fresh clues on interest rates, a key input for valuing big, cash-generating healthcare names. Kitco+1 “Volume is low, so any activity could push the index one way or the other,” said Sam Stovall, chief investment strategist at CFRA Research,
30 December 2025
·
Medtronic (MDT) Stock Update: Dividend Timing, MiniMed IPO Catalyst, and What Investors Should Watch Before Monday’s Open

Medtronic (MDT) Stock Update: Dividend Timing, MiniMed IPO Catalyst, and What Investors Should Watch Before Monday’s Open

NEW YORK, Dec. 28, 2025, 4:09 p.m. ET — Market closed. New York Stock Exchange Medtronic plc (NYSE: MDT) heads into the final full trading week of 2025 with U.S. equities closed for the weekend and futures reopening Sunday evening—setting the stage for Monday’s regular-session restart. The broader market backdrop remains constructive late in the year, with major indexes having pushed to record territory recently and investors still focused on “Santa rally” dynamics and year-end positioning. Investors+1 For Medtronic stock specifically, the most immediate investor questions are straightforward: where MDT finished the last session, what (if anything) hit the newswire
28 December 2025
·
Medtronic (MDT) Stock: Dividend Timing, MiniMed IPO Watch, and What to Know Before the Next NYSE Session

Medtronic (MDT) Stock: Dividend Timing, MiniMed IPO Watch, and What to Know Before the Next NYSE Session

NEW YORK, Dec. 27, 2025, 4:10 p.m. ET — Market Closed (Weekend) Medtronic plc (NYSE: MDT) heads into the weekend with investors balancing a quiet, year-end tape against several company-specific narratives that still matter for 2026: a freshly passed dividend record window, the planned separation of its diabetes business via the MiniMed IPO process, and continued focus on cardiovascular momentum that has helped drive the stock’s 2025 run. With U.S. markets shut until Monday’s open, the immediate question for shareholders isn’t what MDT did minute-to-minute on Saturday—because it didn’t trade—but what the stock’s latest positioning says about sentiment, and what
27 December 2025
···
Medtronic (MDT) Stock After Hours on Dec. 24, 2025: FDA Class I Recall Headline, Options Surge, Dividend Timing, and What to Watch Before Markets Reopen

Medtronic (MDT) Stock After Hours on Dec. 24, 2025: FDA Class I Recall Headline, Options Surge, Dividend Timing, and What to Watch Before Markets Reopen

Medtronic plc (NYSE: MDT) ended the holiday-shortened Christmas Eve session on Wednesday, December 24, 2025 essentially flat-to-lower, then ticked modestly higher in thin after-hours trading—exactly the kind of “quiet tape” investors often see when U.S. markets close early for the holiday. New York Stock Exchange+2Investor Relations | Medtronic+2 One important calendar note upfront: U.S. stock markets are closed on Thursday, December 25 (Christmas Day) and reopen Friday, December 26—so “tomorrow’s open” for trading purposes is the Friday session. New York Stock Exchange+1 MDT after the bell: price action recap (Dec. 24, 2025) Official close (regular session): Medtronic’s investor relations historical
25 December 2025
Intuitive Surgical (ISRG) stock: What to know before the U.S. market opens on Dec. 15, 2025

Intuitive Surgical (ISRG) stock: What to know before the U.S. market opens on Dec. 15, 2025

As U.S. markets head into Monday’s open (Dec. 15, 2025), Intuitive Surgical, Inc. (NASDAQ: ISRG) is back in focus after a busy stretch of headlines spanning new FDA clearances, competitive pressure rising, and fresh Wall Street calls. Shares most recently traded around $542.32 (based on the latest available pricing ahead of Monday’s session). Below is what investors and watchlists are likely keying on before the opening bell. 1) The newest catalyst: FDA expands da Vinci SP indications (Dec. 10) Intuitive’s most recent company-driven headline is a new U.S. FDA clearance for its da Vinci Single Port (SP) system—expanding indicated use
14 December 2025
·
Medtronic PLC (MDT) Stock Outlook December 7, 2025: Price, Dividend, Hugo Robot FDA Win and 2026 Forecast

Medtronic PLC (MDT) Stock Outlook December 7, 2025: Price, Dividend, Hugo Robot FDA Win and 2026 Forecast

Updated: December 7, 2025 Key Takeaways 1. Medtronic (MDT) Stock Snapshot on December 7, 2025 As of the latest completed trading session (Dec. 5, 2025), Medtronic’s NYSE‑listed shares closed at $101.36, with modest after‑hours trading around $101.31. StockAnalysis Key stats at a glance: Trading over the last week has been choppy as markets digest macro headlines and rotations within healthcare. On Dec. 1, MDT fell about 1.9% to $103.34, underperforming the S&P 500 and Dow. A day later, it slipped another 1.3% to $102.03, leaving it around 4% below its recent 52‑week high of $106.33. MarketWatch+1 Even so, post‑earnings commentary
7 December 2025
·
Medtronic (MDT) Stock News Today: Hugo Robot FDA Clearance, Diabetes Spin-Off and Dividend Strength Shape 2026 Outlook

Medtronic (MDT) Stock News Today: Hugo Robot FDA Clearance, Diabetes Spin-Off and Dividend Strength Shape 2026 Outlook

As of the close on 5 December 2025, Medtronic plc (NYSE: MDT) stock trades around $101.36–$101.39 per share, giving the medical device giant a market capitalization of roughly $130 billion, a P/E ratio near 27.4, and a dividend yield of about 2.8%. MarketBeat+2StockAnalysis+2 In the first week of December, Medtronic has delivered a flurry of stock‑moving news: a new FDA clearance for its Hugo™ robotic-assisted surgery system, a U.S. launch of its next‑gen MiniMed™ 780G insulin pump with Abbott’s Instinct™ sensor, a fresh quarterly dividend declaration, and ongoing progress toward the spin‑off of its Diabetes business. At the same time,
6 December 2025
·
Medtronic (MDT) Stock Near 52‑Week High as Truist Hikes Target and Norges Bank Buys Big

Medtronic (MDT) Stock Near 52‑Week High as Truist Hikes Target and Norges Bank Buys Big

Medtronic plc (NYSE: MDT) is back in the spotlight on 29 November 2025, with its stock trading close to record levels after a strong earnings beat, a fresh wave of analyst updates and sizeable moves from some of the world’s biggest institutional investors. Below is a deep dive into what’s moving Medtronic stock today, and what it could mean for investors watching MDT on Google News and Discover. Snapshot: Where Medtronic Stock Stands Now As of the latest close on 28 November 2025, Medtronic shares trade around $105.33, giving the company a market capitalization of roughly $135 billion.Stock Titan+2Macrotrends+2 Key
30 November 2025
·
Medtronic (MDT) Soars as Q2 FY26 Earnings Beat Expectations and 2026 Outlook Is Raised on Pulsed Field Ablation Strength

Medtronic (MDT) Soars as Q2 FY26 Earnings Beat Expectations and 2026 Outlook Is Raised on Pulsed Field Ablation Strength

Published: November 18, 2025 Medtronic plc (NYSE: MDT) is back in the spotlight today after reporting stronger‑than‑expected results for the second quarter of fiscal 2026 and raising its full‑year outlook. The medical technology giant delivered solid revenue and earnings growth, highlighted powerful momentum in its cardiac ablation franchise, and signaled confidence in accelerating growth in the second half of the year. Medtronic News+1 Shares of Medtronic jumped intraday to around $100–101, up roughly 4–5% after the announcement, as investors reacted to a classic “beat‑and‑raise” quarter. ChartMill Q2 FY26 by the numbers: solid beat on revenue and EPS For the quarter
18 November 2025
···
Biotech Breakthroughs & Pharma Shakeups – Global Health Roundup (Aug 20–21, 2025)

Biotech Breakthroughs & Pharma Shakeups – Global Health Roundup (Aug 20–21, 2025)

Industry & Corporate Developments Mergers, Acquisitions & Partnerships Regulatory & Drug Approval Updates Public Health & Policy Research & Clinical Breakthroughs Sources: Reuters, Politico, HealthLeaders, BioPharma Dive, FierceBiotech, Pharmaceutical Executive, Technology Networks, McGill University reuters.com reuters.com healthleadersmedia.com reuters.com fiercebiotech.com reuters.com reuters.com technologynetworks.com technologynetworks.com.
21 August 2025
······

Stock Market Today

Amazon stock tumbles on $200 billion AI spend plan — what to know before Monday

Amazon stock tumbles on $200 billion AI spend plan — what to know before Monday

7 February 2026
Amazon shares fell 5.6% to $210.32 on Friday after the company projected about $200 billion in 2026 capital expenditures, triggering investor concern over AI spending. The stock had already dropped 11.5% after-hours Thursday. Amazon forecast Q1 net sales of $173.5–$178.5 billion and operating income of $16.5–$21.5 billion. Analyst Gil Luria downgraded Amazon, citing rising investment as its cloud lead narrows.
AMD stock jumps 8% in chip rebound — what investors are watching before Monday

AMD stock jumps 8% in chip rebound — what investors are watching before Monday

7 February 2026
AMD shares jumped 8.2% to $208.44 Friday, trading on heavy volume as chip stocks rebounded and the Dow closed above 50,000 for the first time. The Philadelphia Semiconductor Index rose 5.7% after Amazon’s AI spending plans lifted sector estimates. Nvidia’s CEO cited surging AI chip demand. AMD’s rally followed a weak revenue outlook earlier in the week.
Go toTop